期刊文献+

5-氮杂-2’-脱氧胞苷调控RASSF1A基因表达对子宫内膜癌HEC-1-B细胞增殖及凋亡的影响 被引量:3

Effects of 5-Aza-2'-deoxycytidine on proliferation and apoptosis by modulating RASSF1A gene expression in human endometrial carcinoma cell line HEC-1-B
暂未订购
导出
摘要 目的:探讨甲基化转移酶抑制剂5-氮杂-2’-脱氧胞苷(5-Aza-2’-deoxycytidine,5-Aza-CdR)对人子宫内膜癌(Humanendometrial cancer,HEC)-1-B细胞增殖和凋亡的作用及其可能机制。方法:应用不同浓度的5-Aza-CdR处理HEC-1-B细胞,甲基化特异PCR(Methylation-specific polymerase chain reaction,MSP)法检测处理前后RAS相关域家族1A(RAS association do-main family 1A,RASSF1A)基因甲基化状态,应用RT-PCR方法检测RASSF1A基因mRNA表达,MTT法检测细胞增殖,流式细胞术检测细胞凋亡率。结果:HEC-1-B细胞RASSF1A基因启动子区呈高甲基化状态,经过5-Aza-CdR处理后,RASSF1A基因启动子区呈去甲基化状态,其mRNA重新表达,细胞生长受到抑制,细胞凋亡增加。结论:5-Aza-CdR能够逆转RASSF1A基因甲基化状态,调控RASSF1A基因表达,并能有效地抑制HEC-1-B细胞的增殖和诱导细胞调亡。 Objective:To investigate the effects of 5-aza-2'-deoxycytidine(5-Aza-CdR) on the proliferation and apoptosis in human endometrial cancer(HEC)HEC-1-B cells and the possible mechanism.Methods:HEC-1-B cells were treated with different concentrations of DNA methytransferase inhibitor 5-Aza-CdR.Methylation-specific polymerase chain reaction(MSP) was used to detect promoter methylation status of RAS association domain family 1A(RASSF1A) gene and RT-PCR was used to detect re-expression of mRNA.Furthermore,cell growth was estimated by MTT assay and cell apoptosis rate was estimated by flow cytometry.Results:Promoter hypermethylation of the RASSF1A gene was detected in HEC-1-B cells.After treatment with 5-Aza-CdR,the promoter region of the RASSF1A gene exhibited a demethylation status,and RASSF1A gene was re-expressed.Meanwhile,the cellular growth activity decreased and cell apoptosis increased.Conclusions:The 5-Aza-CdR could reverse methylation of RASSF1A gene to regulate the expression of RASSF1A gene,and could effectively inhibit the cellular proliferation and induce apoptosis of endometrial carcinoma cells.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2012年第6期525-527,共3页 Journal of Chongqing Medical University
关键词 子宫内膜癌 5-氮杂-2’-脱氧胞苷 RASSF1A基因 甲基化 endometrial carcinoma 5-Aza-2'-deoxycytidine RASSF1A gene methylation
  • 相关文献

参考文献12

  • 1Saghir F S,Rose I M,Dali A Z,et al.Gene expression profiling and cancer-related pathways in type I endometrial carcinoma[J].Int J Gy- necol Cancer, 2010,20(5) :724-731.
  • 2Di Cristofano A,Ellenson L H.Endometrial carcinoma[J].Annu Rev Pathol, 2007,2:57-85.
  • 3Laird P W.Cancer epigenetices[J].Hum Mol Genet,2005,14(sl): 65-76.
  • 4Park S Y,Kim B H, Kim J H,et al.Methylation profiles of CpG is- land loci in major types of human eancers[J].J Korean Med Sci,2007, 22(2):311-317.
  • 5Doruninger H,Vos M D,Clark C J.The RASSF1A tumor surppres- sor[J].J Cell Sci,2007,120(Pt 18):3167-3172.
  • 6Pfeifer G P,Yoon J H,Liu L,et al.Methylation of the RASSF1A gene in human cancers[J].Biol Chem,2002,383(6):907-914.
  • 7Kang S,Lee J M,Joon E S,et al.RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-as- sociated endometrial carcinoma[J]. Int J Cancer, 2006, 119 ( 6 ) : 1316- 1321.
  • 8Pijnenborg J M,Dam-de Veen G C,Kisters N,et al.RASSF1A methylation and K-ras and B-raf mutation and recurrent endometrial cancer[J].Ann Oncol, 2007,18 (3) :491-497.
  • 9Fiegl H,Gattringer C,Widschwendter A,et al.Methylated DNA col- lected by tampons:a new tool to detect endometrial cancer[J].Cancer Epidemiol Biomarkers Prev, 2004, 13 (5) :882-888.
  • 10Jo H, Kim J W, Kang C H,et al.Association of promoter hyperme- thylation of the RASSF1A gene with prognostic parameters in endome- trial cancer[J].Oncol Res, 2006,16 ( 4 ) :205 -209.

同被引文献34

  • 1虞斌,许培箴.子宫内膜癌肿瘤标志物的研究进展[J].现代生物医学进展,2006,6(11):139-141. 被引量:3
  • 2南芳芳,姜洁,夏敏,董,冯进波.RASSF1 A基因在子宫内膜癌组织中的表达及意义[J].山东大学学报(医学版),2007,45(1):94-96. 被引量:5
  • 3Hall M,Peters G.Genetic alterations of cyclins,cyclin-dependent kinases,and Cdk inhibitors in human cancer[J].Adv Cancer Res,1996,68:67-108.
  • 4Dobrzycka B,Terlikowski SJ.Biomarkers as prognostic factors in endometrial cancer[J].Folia Histochem Cytobiol,2010,48(3):319-322.
  • 5Kondo S,Asano M,Matsuo K,et al.Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients[J].Biochim Biophys Acta,1994,1221(2):211-214.
  • 6Kamat AA,Merritt WM,Coffey D,et al.Clinical and biological significance of vascular endothelial growth factor in endometrial cancer[J].Clin Cancer Res,2007,13(24):7487-7495.
  • 7Gornall RJ,Anthony FW,Coombes EJ,et al.Investigation of women with endometrial carcinoma using serum vascular endothelial growth factor(VEGF)measurement[J].Int J Gynecol Cancer,2001,11(2):164-166.
  • 8Mc Meekin DS,Sill MW,Benbrook D,et al.A phaseⅡtrial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers:a Gynecologic Oncology Group study[J].Gynecol Oncol,2007,105(2):508-516.
  • 9马海琴,徐浩.VEGF与m TOR在子宫内膜癌组织中的表达及意义[J].中外健康文摘,2013,10(7):173-174.
  • 10Coenegrachts L,Schrauwen S,Van Bree R,et al.Increased expression of placental growth factor in high-grade endometrial carcinoma[J].Oncol Rep,2013,29(2):413-418.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部